Investment Summary

EQT Life Sciences Invests In OneProjects

On June 23, 2020, growth capital firm EQT Life Sciences invested in medical products company OneProjects

Investment Highlights
  • This is EQT Life Sciences’ 13th transaction in the Medical Products sector.
  • This is EQT Life Sciences’ 3rd transaction in Ireland.

Investment Summary

Date 2020-06-23
Target OneProjects
Sector Medical Products
Investor(s) EQT Life Sciences
Deal Type Venture

Target

OneProjects

Dublin , Ireland
OneProjects is a medical device company specialising in cardiac imaging innovations and operates at the intersection of hardware, software and data science. OneProjects was founded in 2017 and is based in Dublin, Ireland.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

EQT Life Sciences


Category Growth Capital Firm
Founded 1987
PE ASSETS 3.5B EUR
Size Large
Type Sector Focused
DESCRIPTION

EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.


DEAL STATS #
Overall 29 of 47
Sector: Medical Products M&A 13 of 14
Type: Venture M&A Deals 23 of 39
Country: Ireland M&A 3 of 5
Year: 2020 M&A 4 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-01 IlluminOss

East Providence, Rhode Island, United States

IlluminOss is a commercial stage medical device company focused on designing, developing, and marketing orthopedic fracture repair and stabilization products that leverage its proprietary system. IlluminOss was founded in 2007 and is based in East Providence, Rhode Island.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-08 Xilis

Durham, North Carolina, United States

Xilis is a pioneering company using its MicroOrganoSphere™ (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and development. Xilis was founded in 2019 and is based in Durham, North Carolina.

Buy -